Mary Fakorede, MBBS, is a family physician. She completed medical school in Nigeria, and Family Medicine residency at the Department of Community and Family Medicine at Howard University Hospital in Washington DC before joining the Addiction Medicine fellowship at Johns Hopkins Bayview. Her area of interest is integration of substance use disorder treatment in primary care. In her spare time, she enjoys spending time with family.

Noelle Martinez, M.D., MPH, completed her residency in family medicine at University of California San Francisco (UCSF). Her current work explores patient autonomy and patient-directed discharges (commonly known as AMA discharges) as well as research on the use of urine toxicology and medical system interaction with the child welfare system. She is a REACH scholar (Recognizing and Eliminating disparities in Addiction through Culturally-informed Healthcare) and seeks to dismantle the structures and practices that lead to inequities for racial/ethnic minoritized patients who use drugs. Outside of work, she enjoys playing her cello, reading, hiking (slowly), and pondering life's mysteries.

Savitha Racha, M.D., completed her internal medicine residency at Cooper University Hospital in Camden, NJ. She discovered her interest in addiction medicine as a student at Boston University School of Medicine where she volunteered with the Outreach Van Project. Her research focuses on the medical complications of addiction such as endocarditis as a result of injection drug use. After fellowship, she be returning to Cooper University Hospital as an addiction medicine consultant.

Publications

• Infective endocarditis in people who inject drugs: A scoping review of clinical guidelines
• Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges

Lea Selitsky, M.D., MPH earned her medical degree at Wayne State University before completing her residency in internal medicine at The Johns Hopkins Hospital. She is passionate about harm reduction and expanding access to addiction treatment in primary care. She will be working at the Philadelphia Veteran's Affairs Hospital after completing her fellowship.

Publications

• Higher buprenorphine dose associated with increased treatment retention at low threshold buprenorphine clinic: A retrospective cohort study
• Infective endocarditis in people who inject drugs: A scoping review of clinical guidelines

Ashish Thakrar, M.D., is an Internist and Addiction Medicine Specialist in the National Clinician Scholars Program at the University of Pennsylvania. Before his addiction medicine fellowship, he completed residency at the Johns Hopkins Osler Internal Medicine Training Program in the Urban Health-Primary Care track. His research and advocacy focus on improving clinical care for patients with severe substance use disorders, with a focus on responding to the unique challenges of fentanyl and other synthetic drugs. He continues to work clinically in primary care and hospital-based addiction medicine.

Publications

• Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists
• Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder

Jessica Ratner, M.D., is a primary care doctor trained in Internal Medicine and Pediatrics. She completed medical school at the University of Pennsylvania and residency at the Hopkins Urban Health Med-Peds Program, before joining the Addiction Medicine fellowship at Hopkins Bayview. She is interested providing clinical care, developing programs, and strengthening policies that support underserved families impacted by addiction and trauma. She is currently an Assistant Professor in the Hopkins Division of Addiction Medicine, seeing patients at the Comprehensive Care Practice and the Center for Addiction and Pregnancy and working as a consultant to the Baltimore City Health Department on efforts related to peripartum substance use disorders.

Publications

• Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists
• Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations

Joseph (Seffy) Muller, M.D., is a primary care internist and pediatrician as well an addiction specialist working in Washington, D.C. He is the director of addiction medicine at Unity Health Care, a large federally qualified health center. In that capacity he is also the medical director of the Opioid Treatment Program at the D.C. Department of Corrections.

Jasleen Salwan, M.D., MPH is a board-certified Addiction Medicine and Internal Medicine physician practicing integrated primary care and substance use disorder treatment at Montgomery Family Medicine in Silver Spring, Maryland. She also serves on the education faculty for the American Society of Addiction Medicine and works as a consultant for the Washington, DC Addiction Consultation Service. She is grateful to her wonderful mentors at Hopkins Bayview as well as at her prior training institutions, including the Yale Primary Care Program, where she completed her residency, and the Icahn School of Medicine at Mount Sinai, where she earned her medical and public health degrees.

Jarratt Pytell, M.D., was the 2018-19 fellow in Addiction Medicine at Johns Hopkins. He received his undergraduate degree from the University of Colorado at Boulder. Afterwards, he was accepted into Teach for America and worked as a math teacher at a public school located in New Orleans' Upper Ninth Ward. He then earned his medical degree from Louisiana State University Health Sciences Center, New Orleans. During medical school, he was accepted as an Applied Epidemiology Fellow at the Centers for Disease Prevention and worked for a year in the Division of Waterborne Diseases. He completed his medical residency at Johns Hopkins Bayview Medical Center. After completing his Addiction Medicine fellowship, Jarratt completed a General Internal Medicine fellowship at Johns Hopkins and accepted an academic position at the University of Colorado, Denver in 2022.

Publications

• Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study
• Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice
• Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities
• Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic